SGIOF is no longer actively traded. Data shown reflects verified historical relationships.
2Suppliers
2Customers
1Debt Items
20Related Chains

Shionogi & Co., Ltd. Suppliers

TickerNameConfidenceEvidence
SUPN Supernus Pharmaceuticals, Inc. 72% Reciprocal relationship from SUPN graph: Reciprocal relationship from SGIOF graph: Reciprocal relationship from SUPN graph: . • Shionogi - The Company also has a collaboration agreement with Shionogi…
VXRT Vaxart, Inc. 72% Reciprocal relationship from VXRT graph: Item 8) has no impact on total revenue recognized, it only impacts our net cash flow in the quarter following revenue recognition. We cannot predict with any …

Shionogi & Co., Ltd. Customers

TickerNameConfidenceEvidence
SUPN Supernus Pharmaceuticals, Inc. 72% Reciprocal relationship from SUPN graph: Reciprocal relationship from SGIOF graph: Reciprocal relationship from SUPN graph: Reciprocal relationship from SGIOF graph: Reciprocal relationship from SUPN…
VXRT Vaxart, Inc. 72% Reciprocal relationship from VXRT graph: irements relating to the organization of personnel, buildings and facilities, equipment, control of components and drug product containers and closures, produ…

Shionogi & Co., Ltd. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SGIOF-DEBT Debt stack $4.3B 90% Market cache reports total debt of $4.3B.

Shionogi & Co., Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Shionogi & Co., Ltd..

Shionogi & Co., Ltd. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Shionogi & Co., Ltd..

Shionogi & Co., Ltd. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
HLN Haleon plc 100.00 2
MYGN Myriad Genetics, Inc. 100.00 2
COLL Collegium Pharmaceutical, Inc. 100.00 2
HLNCF Haleon plc 100.00 2
JBIO Jade Biosciences, Inc. 100.00 2
KLRS Kalaris Therapeutics, Inc. 100.00 2
CPMV Mosaic ImmunoEngineering, Inc. 100.00 2
ABT Abbott Laboratories 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
HTGC Hercules Capital, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
SLGL Sol-Gel Technologies Ltd. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
ELVN Enliven Therapeutics, Inc. 100.00 2
DYN Dyne Therapeutics, Inc. 100.00 2
LQDA Liquidia Corporation 100.00 2